Katsumasa Tsurushima
Sakai, 5938304, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Administration Period of Olanzapine as an Antiemetic Drug for Patients on FEC Therapy-A Survey
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 08, 2022
Dimethyl Fumarate Induces Apoptosis via Inhibition of NF-κB and Enhances the Effect of Paclitaxel and Adriamycin in Human TNBC Cells.
Journal: International journal of molecular sciences
Published: June 20, 2022
Bim downregulation by activation of NF-κB p65, Akt, and ERK1/2 is associated with adriamycin and dexamethasone resistance in multiple myeloma cells.
Journal: Clinical and experimental medicine
Published: June 11, 2022
Interleukin 19 suppresses RANKL-induced osteoclastogenesis via the inhibition of NF-κB and p38MAPK activation and c-Fos expression in RAW264.7 cells.
Journal: Cytokine
Published: October 26, 2020
Activation of Serum/Glucocorticoid Regulated Kinase 1/Nuclear Factor-κB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells.
Journal: Biomedicines
Published: October 26, 2020
Gabapentin and Duloxetine Prevent Oxaliplatin- and Paclitaxel-Induced Peripheral Neuropathy by Inhibiting Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Phosphorylation in Spinal Cords of Mice.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 26, 2020
Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells.
Journal: BMC complementary medicine and therapies
Published: September 25, 2019
Inhibition of HSP90 overcomes melphalan resistance through downregulation of Src in multiple myeloma cells.
Journal: Clinical and experimental medicine
Published: June 27, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026